Heart Hospital continues to provide best care to patients

HMC heart hospital

Despite the challenges imposed by the coronavirus pandemic (Covid-19), the Hamad Medical Corporation (HMC) persistently continues providing personalised and innovative treatments through Heart Hospital for the various types of patients, including patients whose health condition requires emergency therapeutic cauterisation to treat strokes and strokes. Treating cardiac and cerebral strokes by removing clots through therapeutic cauterisation is one of the modern methods and techniques that HMC medical teams have been following for many years, as they are the most effective methods, which have proven extremely successful in saving many lives and minimising the negative effects and the consequent damages resulting from these clots. Senior Consultant Cardiologist at the Heart Hospital Dr. Omar al-Tamimi said that despite the Covid-19 pandemic and the precautionary measures taken by hospitals in various parts of the world, the Heart Hospital did not stop providing treatment services to various patients, including emergency therapeutic catheterisation to treat heart attacks, as the medical teams at the Heart Hospital take all necessary precautions and protective measures to, successfully, combat Covid-19. Hence the number of daily heart cases treated in the Heart Hospital is not affected; whereas more than 1000 severe and acute heart strokes have been treated, in 2020, through therapeutic catheterisation, to raise the number of the cases treated since the provisioning of round the clock therapeutic services, seven years ago, to 6000 cases with a total success of 95%. He pointed out that during the pandemic, this emergency catheterisation was performed on a number of patients who were found to have Covid-19, adding about 60 cases of those infected with the virus have been successfully treated since the beginning of the pandemic until now.